COMMUNIQUÉS West-GlobeNewswire

-
BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program
11/06/2018 -
DRAFT RESOLUTIONS of Annual General Meeting of Shareholders of joint stock company “Grindeks” to be held on 26 June 2018
11/06/2018 -
Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/CPPS
11/06/2018 -
RECORDATI ACQUIRES NATURAL POINT S.R.L. IN ITALY
11/06/2018 -
Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization
11/06/2018 -
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Analogic Shareholders Vote “For” Proposed Analogic Acquisition by Affiliate of Altaris Capital Partners
11/06/2018 -
Advantis Corp. Expanding Into Two New Locations, As Demand Continues to Drive Further Production Capacity
11/06/2018 -
Comprehensive Pharmacy Services Expands Telepharmacy Solutions
11/06/2018 -
TRHC’s SinfoníaRx named a “Top Company to Work for in Arizona” for Third Year in a Row
11/06/2018 -
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent for Use of Stem Cells to Treat Cancer and Autoimmune Disorders
11/06/2018 -
70% of Canadian Men’s Chronic Health Conditions are Caused by Lifestyle, not Genetics
11/06/2018 -
PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the Association for Professionals in Infection Control and Epidemiology Annual Conference June 13-15th
11/06/2018 -
Achaogen Highlights Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting
11/06/2018 -
The American Health Council Physician Board Welcomes Marvin Faulkner, DO, BA
11/06/2018 -
Paratek Presents New Analysis from Combined Phase 3 Skin Infection Studies Highlighting Efficacy of Omadacycline in Treating Drug Resistant S. aureus at ASM Microbe 2018
11/06/2018 -
Allena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors
11/06/2018 -
OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
11/06/2018 -
Interpace Diagnostics Announces Coverage of Thyroid Testing by Blue Cross Blue Shield of Florida
11/06/2018 -
Nkarta Therapeutics Announces Exclusive License to Natural Killer Cell Technology From National University of Singapore and St. Jude Children’s Research Hospital
11/06/2018
Pages